Assessment of oral health condition in recipients of allogeneic hematopoietic cell transplantation
AUTOR(ES)
Reis, Thiago de Carvalho; Bortolotti, Fernanda; Innocentini, Lara Maria Alencar Ramos; Ferrari, Tatiane Cristina; Ricz, Hilton Marcos Alves; Cunha, Renato Luiz Guerino; Costa, Thalita Cristina de Mello; Macedo, Leandro Dorigan de
FONTE
Hematology, Transfusion and Cell Therapy
DATA DE PUBLICAÇÃO
2022
RESUMO
ABSTRACT Objective: The objective of this study was to evaluate the oral health condition and dental treatments performed in patients in pre-allogeneic HCT. Method: The records of patients treated during 2018 at a Brazilian HCT service were reviewed. The following oral health data were obtained: 1. Decayed, missing and filled teeth / correlated index for primary dentition (DMFT/dmft); 2. Quality of oral hygiene and 3. Dental pathologies: 3.1 Periodontal infectious focus, 3.2 Endodontic infectious focus and 3.3 Carie incidence. All dental procedures performed were surveyed. Results: Thirty-three patients were included, with a mean age of 28.42 (±16.37), 20 male (60%) and 13 female. The average DMFT/dmft found in this study was 10.24 (± 8.37), similar to the index found in the population in southeastern Brazil. The younger study population presented a DMFT/dmft considered high, when compared to the general population. A total of 27.2% of the patients had active caries lesions, 33.3%, foci of periodontal infection, 15.1%, endodontic infectious focus and 40%, poor oral hygiene. Almost half of the patients (48.4%) had to undergo dental intervention, 24.2% needing periodontal scaling, 21.2%, fillings and 12.1%, tooth extractions. Conclusion: We conclude that the studied population had an important incidence of dental pathologies and infectious conditions that could complicate throughout HCT, especially in younger patients, therefore presenting a high demand for dental treatment in the pre-HCT. Studies that assess the impact of dental conditioning on the outcomes of HCT with an emphasis on dental infectious complications, days of hospitalization and survival are necessary.”
Documentos Relacionados
- Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
- Quality of life after allogeneic hematopoietic cell transplantation
- Response:Solid cancers after allogeneic hematopoietic cell transplantation
- Difficulties in the revaccination program of hematopoietic stem cell transplantation recipients
- Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation